Troponin I: An update on clinical utility and method standardization

Annals of Clinical and Laboratory Science

Volumn 30, Issue 4, 2000, Pages 412-421

  Laurino, J P ^a  

^a UNIVERSITY OF TAMPA   (United States)

Author keywords

Acute myocardial infraction; Platelet receptor inhibition; Standardization; Troponin I; Unstable angina

Indexed keywords

TROPONIN I;

ACUTE HEART INFARCTION; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; HUMAN; LABORATORY DIAGNOSIS; MYOCARDIAL DISEASE; PRIORITY JOURNAL; REVIEW; STANDARDIZATION; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; CHEMISTRY, CLINICAL; HUMAN; LABORATORIES, HOSPITAL; MYOCARDIAL INFARCTION; REPRODUCIBILITY OF RESULTS; TROPONIN I;

EID: 0033782259     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Structure of muscle filaments studied by electron microscopy
2. The mechanism of muscle contraction
3. Myosin structure and function in cell motility
4. Tropomyosin crystal structure and muscle regulation
5. Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction
6. Ultrastructure of the calcium release channel of sarcoplasmic reticulum
7. Cardiac troponins in acute coronary syndromes
8. Endothelium and acute coronary syndromes
9. Molecular bases of the acute coronary syndromes
10. Can we predict future coronary events in patients with stable coronary artery disease?
11. International diagnostic criteria for acute myocardial infarction and acute stroke
12. Unstable angina: Prognosis of the individual patient
13. Relationship of prior myocardial infarction to false-positive electrocardiographic diagnosis of acute injury in patients with chest pain
14. Eligibility for intravenous thrombolysis in suspected acute myocardial infarction
15. Management of acute coronary syndromes based on risk stratification of biochemical markers: An idea whose time has come
16. Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: Improving timing, thrombolytic efficacy and ventricular function
17. Candidates for thrombosis among emergency room patients with acute chest pain. Potential true- and false-positive rates
18. The risks of thrombolysis in patients without acute myocardial infarction
19. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I
20. Cardiac troponin I for the diagnosis of acute myocardial infarction in the emergency department
21. Multicenter clinical and analytical evaluation of the AxSYM troponin I immunoassay to assist in the diagnosis of myocardial infarction
22. Strategies for the early diagnosis of acute myocardial infarction using biochemical markers
23. Unstable angina: An etiologic approach to management
24. National Academy of Clinical Biochemistry standards of laboratory practice: Recommendations for the use of cardiac markers in coronary artery diseases
25. Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: Proposed revisions
26. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA investigators
27. Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
28. Cardiac troponin I levels and clinical outcomes in patients with acute coronary syndromes
29. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group (Thrombin Inhibition in Myocardial Ischemia)
30. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: A Thrombolysis in Myocardial Infarction (TIMI)-IIB substudy
31. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina
32. Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies
33. Redefining medical treatment in the management of unstable angina
34. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction
35. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of triofiban
36. A double-blind, randomized study of the effect of immediate intravenous nitroglycerine on the incidence of post-procedural chest pain and minor myocardial necrosis after elective coronary stenting
37. Plasma troponin I and troponin I after minimally invasive coronary bypass surgery
38. Cardiac troponin: A new serum marker of myocardial injury in sepsis
39. Cardiac troponins in congestive heart failure
40. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I
41. Evaluation of a rapid whole blood ELISA for quantification of troponin I in patients with acute chest pain
42. Cardiac troponin I measurement with the ACCESS immunoassay system: Analytical and clinical performance characteristics
43. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I
44. False-positive troponin I in the MEIA due to the presence of rheumatoid factors in serum
45. Analytic and clinical evaluation of the Abbott AxSYM cardiac troponin I assay
46. False increase of cardiac troponin I with heterophilic antibodies
47. False increases of troponin I attributable to incomplete separation of serum
48. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: Lower recoveries in early than in late phases of myocardial injury
49. Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays
50. Human cardiac troponin I: Precise identification of antigenic epitopes and prediction of secondary structure
51. Antigenic definition of cardiac troponin I
52. Pattern formation on cardiac troponin I by consecutive phosphorylation and dephosphorylation
53. Effects of protein kinase A phosphorylation on signaling between cardiac troponin I and the N-terminal domain of cardiac troponin C
54. Degradation of cardiac troponin I: Implication for reliable immunodetection
55. Degradation of human cardiac troponin I after myocardial infarction
56. Determination of cardiac troponin I forms in the blood of patients with acute myocardial infarction and patients receiving crystalloid or cold blood cardioplegia
57. Troponin I degradation and covalent complex formatin accompanies myocardial ischemia/reperfusion injury
58. Transgenic mouse model of stunned myocardium
59. Specific degradation of troponin T and I by mu-calpain and its modulation by substrate phosphorylation
60. Role of troponin I proteolysis in the pathogenesis of stunned myocardium
61. +2-sensitivity change and troponin loss in cardiac natural actomyosin after coronary occlusion
62. Binding of cytosolic proteins to myofibrils in ischemic rat hearts
63. Comparison of immunoreactivity of five human cardiac troponin I assays toward free and complexed forms of the antigen: Implications for assay discordance
64. Standardization of cardiac troponin I assays: Pilot evaluation of ten candidate reference materials
65. Impact of antibody specificity and calibration material on the measure of agreement between methods for cardiac troponin I